Anika Therapeutics has been granted a patent for an implant delivery system that secures an implant to an anchor without transmitting biasing force to the bone. The system includes a driver, biasing body, and suture, providing a unique solution for orthopedic procedures. GlobalData’s report on Anika Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Anika Therapeutics Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Anika Therapeutics, was a key innovation area identified from patents. Anika Therapeutics's grant share as of May 2024 was 51%. Grant share is based on the ratio of number of grants to total number of patents.

Implant delivery system for securing implant to anchor

Source: United States Patent and Trademark Office (USPTO). Credit: Anika Therapeutics Inc

A recently granted patent (Publication Number: US11998453B2) discloses a novel system designed for implantation in patients, particularly for replacing a portion of the articular surface. The system includes an anchor to be secured in the bone beneath the articular surface, an implant to replace the surface, and a suture for securing the anchor and implant together. An implant delivery system is also part of the invention, comprising a driver and a biasing body to facilitate the implantation process. The system aims to generate a biasing force to urge the implant into engagement with the anchor without transmitting the force to the bone, ensuring a secure and effective implantation process.

Furthermore, the patent claims detail additional features of the system, such as the inclusion of a cradle in the suture to engage the anchor, a biasing body to maintain a separation angle of the cradle, and suture alignment guides for this purpose. The driver and anchor are designed to be coupled to transmit torque, while the biasing body self-aligns with the implant during the application of the biasing force. The suture's path through the system is carefully outlined, passing through the biasing body and driver for optimal functionality. Overall, the system's design and components aim to provide a reliable and efficient method for implanting and securing implants in patients, particularly in the context of articular surface replacement surgeries.

To know more about GlobalData’s detailed insights on Anika Therapeutics, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.